2019年-検査技術科学専攻 学術論文など(総説?原著)

  1. Ichimata S, Aoyagi D, Yoshinaga T, Katoh N, Kametani F, Yazaki M, Uehara T, Shiozawa S: A case of spheroid-type localized lactoferrin amyloidosis in the bronchus. Pathol Int 69: 235-240, 2019.

  2. Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Virchows Arch 474: 79-86, 2019.

  3. Fujita T, Yoshida H, Osaka S, Hirose Y, Goto M, Nagano N, Takahashi T.:Comparison of caracteristics of Streptococcus dysgalactiae subsp. equisimilis isolates causing repetitive vs single infections. Ann Lab Med 39: 488-492, 2019.

  4. Furukawa S, Matsuda K, Sugano M, Uehara T, Honda T: NLRP3 upregulation in A549?cells co-cultured with THP-1 macrophages under hypoxia via deregulated TGF-β signaling. Exp Cell Res 383(1): 111506. doi: 10.1016/j.yexcr.2019.111506. 2019.

  5. Hatsumi N, Miyawaki S, Yamauchi T, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Machida S, Nishii K, Honda S, Ohnishi K, Naoe T: Japan Adult Leukemia Study Group (JALSG). Phase II study of FLAGM (fludarabine?+?high-dose cytarabine?+?granulocyte colony-stimulating factor?+?mitoxantrone) for relapsed or refractory acute myeloid leukemia. Int J Hematol 109: 418-425. 2019.

  6. Hayashi W, Tanaka H, Taniguchi Y, Iimura M, Soga E, Kubo R, Matsuo N, Kawamura K, Arakawa Y, Nagano Y, Nagano N.: Acquisition of mcr-1 and cocarriage of virulence genes in Avian Pathogenic Escherichia coli isolates from municipal wastewater influents in Japan. Appl Environ Microbiol 85: pii: e01661-19, 2019.

  7. Ichimata S, Hata Y, Abe R, Yoshinaga T, Katoh N, Kamertani F, Yazaki M, Sekijima Y, Ehara T, Nishida N: An autopsy case of amyloid proximal tubulopathy exhibiting characteristic spheroid-type amyloid deposition Virchow Archiv (in press).

  8. Ichimata S, Kobayashi M, Shimojo H, Katoh N, Yazaki M, Kanno H: Heavy-chain amyloidosis in gastroduodenal biopsies - the histopathological features. Amyloid 26(sup1): 89-90, 2019.

  9. Iimura M, Hayashi W, Arai E, Natori T, Horiuchi K, Matsumoto G, Tanaka H, Soga E, Nagano Y, Nagano N.: Detection of Acinetobacter pittii ST220 co-producing NDM-1 and OXA-820 carbapenemases from a hospital sink in a non-endemic country of NDM. J Glob Antimicrob Resist pii: S2213-7165(19)30305-4, 2019.

  10. Iwaya M, Ota H, Tateishi Y, Nakajima T, Riddell R, Conner JR. Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression. Mod Pathol 32: 884-892, 2019.

  11. Kamijo T, Mukai S, Taira C, Higuchi Y, Okumura N: γD318Y fibrinogen shows no fibrin polymerization due to defective "A-a" and "B-b" interactions, whereas that of γK321E fibrinogen is nearly normal. Thromb Res 182: 150-158, 2019.

  12. Katayama K, Chino S, Kurasawa S, Koyama S, Ishizawa H, Fujimoto K:Classification of pulse wave signal measured by FBG sensor for vascular age and arteriosclerosis estimation. Sensors http://dx.doi.org/10.1109/JSEN.2019.2952833.

  13. Kawachi S, Fujimoto K: Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study. Int J Chron Obstruct Pulmon Dis 14: 1167-1176, 2019.

  14. Kawakami T, Sekiguchi N, Kobayashi J, Yamane T, Nishina S, Sakai H, Hirabayashi Y, Nakazawa H, Ishida F: STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder in natural killer cells. Int J Hematol 109:563-571, 2019 doi.org/10.1007/s12185-019-02625-x

  15. Kimura F,Kobayashi T,Kanai R,Kobayashi Y,Ohtani Y,Ota H,Yamaguchi M,Yokokawa Y,Uehara T,Ishii K: Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia. Diagn Cytopathol 47: 553-563, 2019.

  16. Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y: Late-onset familial Mediterranean fever in Japan. Mod Rheumatol. Jun 25: 1-4, 2019.

  17. Koide S, Hayashi W, Taniguchi Y, Tanaka H, Kimura K, Nagano Y, Arakawa Y, Nagano N.:Potential effect of selective pressure with different β-lactam molecules on the emergence of reduced susceptibility to β-lactams in group B Streptococci. Microbiol Immunol. 63: 65-76, 2019.

  18. Nagano N, Koide S, Hayashi W, Taniguchi Y, Tanaka H, Maeyama Y, Suzuki M, Kimura K,Arakawa Y, Nagano Y. :Population-level transition of capsular polysaccharide types among sequence type 1 group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic. Int J Antimicrob Agents 53: 203-210, 2019.

  19. Nakano R, Nakano A, Abe M, Nagano N, Asahara M, Furukawa T, Ono Y, Yano H, Okamoto R.: Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of Proteus mirabilis in Japan. Heliyon 5: e01291, 2019.

  20. Norazman SH,Nakamura T,Kimura F,Yamaguchi M: Analysis of Quantitative Phase Obtained by Digital Holography on H&E Stained Pathological Samples.Artificial Life and Robotics(AROB) 24: 38-43, 2019.

  21. Ogawa K, Koyama S, Haseda Y, Fujita K, Ishizawa H, Fujimoto K: Wireless, Portable Fiber Bragg Grating Interrogation System Employing Optical Edge Filter. Sensors 19(14): 3222-1-12, 2019.

  22. Saito S, Taira C, Matsuda K, Yanagisawa R, Morita D, Shigemura T, Yoshikawa K, Tanaka M, Sakashita K, Mukai S, Shimodaira S, Koike K, Nakazawa Y: Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia. Leuk Lymphoma 6: 1-4, 2019.

  23. Saito T, Tanaka M, Matsuda K, Honma H, Komori K, Morita D, Nakazawa H, Yanagisawa R, Nakazawa Y: Significance of Molecular Monitoring of T Cells for the Decision of Treatment Strategy for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol 41: 407-409, 2019.

  24. Sato K, Uehara T, Iwaya M, Nakajima T, Miyagawa Y, Suga T, Ota H, Tanaka E. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma. Ann Diagn Pathol 40: 161-165, 2019.

  25. Shigemura T, Matsuda K, Kurata T, Sakashita K, Okuno Y, Muramatsu H, Yue F, Ebihara Y, Tsuji K, Sasaki K, Nakahata T, Nakazawa Y, Koike K: Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia. Br J Haematol 187: 163-173, 2019.

  26. Shintani Y, Okada A, Morita Y, Hamatani Y, Amano M, Takahama H, Amaki M, Hasegawa T, Ohta-Ogo K, Kanzaki H, Ishibashi-Ueda H, Yasuda S, Shimazaki C, Yoshinaga T, Yazaki M, Sekijima Y, Izumi C: Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy. ESC Heart Fail 6: 232-236, 2019.

  27. Soga E, Akiyama M, Ohsaki Y, Hayashi W, Matsumoto T, Oana K, Nagano N, Kawakami Y.:Isolation of a capnophilic and extended-spectrum β-lactamase-producing Proteus mirabilis strain from the urine of an octogenarian male patient with acute pyelonephritis. Jpn J Infect Dis 72: 193-195, 2019.

  28. Soga, E., Akiyama, M., Ohsaki, Y., Hayashi, W., Matsumoto, T., Oana, K., Nagano, N., and Kawakami, Y.: Isolation of a capnophilic and ESBL-producing Proteus mirabilis strain from the urine of an octogenarian male-patient with acute pyelonephritis. Jpn. J. Infect. Dis 72: 193-195, 2019.

  29. Takahashi H, Fujimoto K: Questionnaire survey about disaster preparation for patients on long-term oxygen therapy. Shinshu Univ J 67: 407-416, 2019.

  30. Takeichi N, Fujimoto K: Comparison of impedance measured by the forced oscillation technique and pulmonary functions, including static lung compliance, in obstructive and interstitial lung disease. Int J Chron Obstruct Pulmon Dis 14: 1109-1118, 2019. (corresponding author)

  31. Tanaka H, Hayashi W, Iimura M, Taniguchi Y, Soga E, Matsuo N, Kawamura K, Arakawa Y, Nagano Y, Nagano N.: Wastewater as a probable environmental reservoir of extended-spectrum-β-lactamase genes: detection of chimeric β-lactamases CTX-M-64 and CTX-M-123. Appl Environ Microbiol 85: pii: e01740-19, 2019.

  32. Taniguchi Y, Koide S, Maeyama Y, Tamai K, Hayashi W, Tanaka H, Iimura M, Suzuki M, Nagano Y, Arakawa Y, Nagano N:Predominance of methicillin-resistant Staphylococcus aureus SCCmec type II-CC5 and SCCmec type IV-CC1/CC8 among companion animal clinical isolates in Japan; findings from phylogenetic comparison with human clinical isolates. J Glob Antimicrob Resist. pii: S2213-7165(19)30214-0, 2019.

  33. Tokutake T, Ieko M, Naito S, Yoshida M, Baba H, Kobayashi H, Ishida F: Magnesium-dependent activated partial thromboplastion time assay-simple method for lupus anticoagulation detection, Int J Lab Hematol DOI: 10.1111/ijlh.13134, 2019.

  34. Tsukamoto N, Yokohama A, Higuchi T, Mitsui T, Koiso H, Takizawa M, Shimizu H, Ishizaki T, Matsumoto M, Toyama K, Sakura T, Ogura H, Saitoh T, Ishida F, Murakami H, Tsushima Y, Handa H: Tumor long-axis diameter and SUXmax predict long-term responders in 90 Y-ibritumomab tiuxetan monotherapy. Int J Hematol 109: 91-97, 2019.

  35. Uematsu A, Fujimoto K:Relationship between sympathetic nerve activity evaluated by pulse rate variability and blood pressure early in the morning in sleep disordered breathing. Shinshu Med J 67(4): 241-251, 2019. (corresponding author)

  36. Yanagaisawa R, Matsuda K, Ohga S, Kanegane H, Morimoto A, Okamoto Y, Ohara A, Fukushima K, Sotomatsu M, Nomura K, Saito AM, Horibe K, Ishii E, Nakazawa Y: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol. Int J Hematol 109: 612-617, 2019.

  37. Yanagisawa R, Nakazawa Y, Matsuda K, Yasumi T, Kanegane H, Ohga S, Morimoto A, Hashii Y,Imaizumi M, Okamoto Y, Saito AM, Horibe K, Ishii E : HLH/LCH committee members of the Japan Children's Cancer Group: Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan. Int J Hematol 109: 206-213, 2019.

  38. Hori A, Yamaura M, Morita S, Uehara T, Honda T, Hidaka H: Characterization of galactosyl and lactosyl sulfatide species in human serum by MALDI-TOF mass spectrometry. Ann Clin Biochem 56: 574-582, 2019.

  39. 岸田大,矢﨑正英,中村昭則:家族性地中海熱の診断と治療. 信州医誌 67,229-240, 2019.

  40. 金井崚,大島健吾,小林幸弘,石井恵子,木村文一:Lobular endocervical glandular hyperplasiaならびにその関連病変のDNA複製タンパクに対する免疫組織化学的解析および工学的画像解析.長野県臨床細胞学会誌 33: 28, 2019.

  41. 金井崚,木村文一,小林幸弘,石井恵子,太田浩良:Lobular endocervical glandular hyperplasia の細胞像の数理的解析における濃度共起行列の条件(距離?量子化)検討. 臨床検査学教育 11: 105-106, 2019.

  42. 小堺智文, 高木洋行, 原美紀子, 岩本拓朗, 下平美智子, 大月利香, 櫻井伸子, 太田浩良. 炎症性乳癌の臨床像を示した浸潤性小葉癌組織球様細胞亜型の1例. 医学検査 6: 786-793, 2019

  43. 新井慎平,上條途夢,竹澤由夏,菅野光俊,上原剛,本田孝行,奥村伸生:フィブリノゲン活性の偽低値と異常凝固波形を示したIgA M 蛋白血症の解析.臨床病理 67: 449-456, 2019.

  44. 石田文宏:赤芽球癆の病態と治療. 血液内科 79(2): 175-179, 2019.

  45. 赤羽 貴行, 村山 範行, 吉本 雄太, 玉井 清子, 小穴 こず枝, 川上 由行. Mycobacterium kyorinennse による肺炎の一例. 日赤検査 52: 11-15, 2019.

  46. 塚平俊久, 林誠一, 松本竹久, 太田浩良:Gastric Non-Helicobacter pylori Helicobacter感染胃疾 患の頻度と臨床病理学的解析 7年間にわたる2,508例の連続症例に基づいた単一施設における後方視的 解析.日本ヘリコバクター学会誌21:48-55, 2019

  47. 塚平俊久,林誠一,太田浩良:Ⅱ. 胃 細菌感染症Helicobacter heilmannii-like organism関連胃炎 消化器内視鏡.31:92-95. 2019.

  48. 藤本圭作:COPD治療効果の評価の仕方.日本呼吸ケア?リハビリテーション学会誌 28 (1): 27-32, 2019.

  49. 藤本圭作:肺がん検診を利用してCOPDの早期発見をめざす.特集 COPD早期発見の試み. 監修:井上博雅,日本医事新報,No. 4962: 24-27, 2019.

  50. 平千明, 竹澤由夏, 新井慎平, 松田和之, 上條途夢, 樋口由美子, 奥村伸生:FGA 1238bp欠失を有する無フィブリノゲン血症3例のハプロタイプ解析.医学検査 68: 589-595, 2019.

  51. 平千明, 樋口由美子, 伊澤淳, 奥村伸生, 太田浩良: 生理系専門科目におけるアクティブ?ラーニングの実践. 臨床検査学教育11: 195-199, 2019.